- What are the top holdings of BIOY?
- A machine-readable holdings disclosure for GraniteShares YieldBOOST Biotech ETF (BIOY) is not available from our data sources. Fund families sometimes register portfolio filings under a sibling share class or outside the SEC's structured datasets. Rather than estimate, we leave the section blank; the issuer's website carries the authoritative portfolio list.
- What sectors does BIOY invest in?
- GraniteShares YieldBOOST Biotech ETF (BIOY) allocates across the sectors shown above. The largest exposure tops the list; the rest follow in descending weight order.
- What sector is BIOY most exposed to?
- BIOY's full sector breakdown is on the Sectors tab. The largest sector weight is shown there along with the rest of the allocation.
- Is BIOY a US-only fund?
- The country allocation card on this page shows BIOY's geographic exposure. Funds with > 95% US weight are effectively US-only; international or global funds will show meaningful weights across multiple countries.
- What does BIOY invest in?
- The GraniteShares YieldBOOST Biotech ETF, an exchange-traded fund launched by GraniteShares Inc. under the umbrella of the GraniteShares ETF Trust, is managed by GraniteShares Advisors LLC. This U.S.-domiciled fund primarily allocates capital to the public stock markets within the United States. Its investment approach involves constructing its portfolio using derivative instruments, such as options, to gain exposure to companies operating across the healthcare, pharmaceutical, biotechnology, and life sciences industries. The ETF seeks a diverse selection of both growth and value stocks, encompassing businesses of varying market capitalizations.
